REFILE-BRIEF-Diamyd Medical increases investment in stem cell activity – Reuters
REFILE-BRIEF-Diamyd Medical increases investment in stem cell activityReutersIncreases investment in stem cell activity. * Says invests an additional 0.8 million Swedish crowns ($93,134) in Cellaviva AB, a Swedish commercial biobank for stem cells Sour… Continue reading
